[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) Complexes, Compounds for the Endocrine Therapy of Breast Cancer - Mode of Action I: Antitumor Activity Due to the Reduction of the Endogenous Estrogen Level.

Autor: Sabine Schertl, Rolf W. Hartmann, Christine Batzl-Hartmann, Günther Bernhardt, Thilo Spruß, Karin Beckenlehner, Marion Koch, Rudolf Krauser, Richard Schlemmer, Helmut Schönenberger
Zdroj: Archiv der Pharmazie; Jun2004, Vol. 337 Issue 6, p335-348, 14p
Databáze: Complementary Index
Externí odkaz: